Cite

HARVARD Citation

    Hershberger, C. et al. (2021). Salivary metabolites are promising non‐invasive biomarkers of hepatocellular carcinoma and chronic liver disease. Liver Cancer International. 2 (2), pp. 33-44. [Online]. 
  
Back to record